ATF6 and Parkinson disease: Increased expression levels of ATF4 and ATF6 90 kDa at stages 5–6 (p < 0.05), and reduced GRP94 expression levels at stages 3–4 and 5–6 (p < 0.01), were found in the substantia nigra in PD (Fig. 9a).